Ronald A. Morton

5.2k total citations · 1 hit paper
49 papers, 4.0k citations indexed

About

Ronald A. Morton is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Ronald A. Morton has authored 49 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Ronald A. Morton's work include Prostate Cancer Treatment and Research (21 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Cancer-related gene regulation (10 papers). Ronald A. Morton is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Cancer-related gene regulation (10 papers). Ronald A. Morton collaborates with scholars based in United States, South Korea and Japan. Ronald A. Morton's co-authors include Mitchell S. Steiner, William B. Isaacs, Patrick C. Walsh, Patrick C. Walsh, G. Steven Bova, James D. Brooks, Charles M. Ewing, David M. Quinlan, P A Campbell and Wu‐Shiun Hsieh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Ronald A. Morton

49 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.

1994 641 citations Ronald A. Morton, James D. Brooks et al. profile →

Peers

Countries citing papers authored by Ronald A. Morton

Since Specialization

Citations

This map shows the geographic impact of Ronald A. Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald A. Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald A. Morton more than expected).

Fields of papers citing papers by Ronald A. Morton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald A. Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald A. Morton. The network helps show where Ronald A. Morton may publish in the future.

Co-authorship network of co-authors of Ronald A. Morton

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald A. Morton. A scholar is included among the top collaborators of Ronald A. Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald A. Morton. Ronald A. Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness of convective water vapor energy therapy versus prostatic urethral lift for symptomatic benign prostatic hyperplasia: a systematic review and indirect comparison 2021 ·World Journal of Urology ·Christopher T. Tallman, (unknown), Natalia Hernández, Ronald A. Morton, (unknown), Ricardo R. González	8
2	Clinical Trial Design for the Development of New Therapies for Nonmuscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public Workshop 2013 ·Urology ·Jonathan P. Jarow, Seth P. Lerner, Paul G. Kluetz, (unknown), Rajeshwari Sridhara, Dean F. Bajorin, Sam S. Chang, Colin P. Dinney, Susan Groshen, Ronald A. Morton, Michael A. O’Donnell, Diane Zipursky Quale, Mark Schoenberg, John D. Seigne, Bhadrasain Vikram	60
3	Preclinical Characterization of a Novel Diphenyl Benzamide Selective ERα Agonist for Hormone Therapy in Prostate Cancer 2012 ·Endocrinology ·Christopher C. Coss, Amanda Jones, Deanna N. Parke, Ramesh Narayanan, Christina M. Barrett, Jeffrey D. Kearbey, Karen A. Veverka, Duane D. Miller, Ronald A. Morton, Mitchell S. Steiner, James T. Dalton	6
4	Factors Associated With Vertebral Fractures in Men Treated With Androgen Deprivation Therapy for Prostate Cancer 2011 ·The Journal of Urology ·Philip J. Saylor, Ronald A. Morton, Michael L. Hancock, K. Gary Barnette, Mitchell S. Steiner, Matthew R. Smith	22
5	Prostate specific antigen as a clinical biomarker for prostate cancer: What’s the take home message? 2005 ·Cancer Biology & Therapy ·(unknown), Moon Soo Koh, (unknown), (unknown), Robert D. Ray, Ronald A. Morton, (unknown)	9
6	Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells 2004 ·Oncogene ·Isaac Yi Kim, (unknown), Dug Keun Lee, (unknown), Moses M. Kim, Seong‐Jin Kim, Ronald A. Morton	65
7	Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. 2002 ·PubMed ·Isaac Yi Kim, Do Hwan Seong, Byung-Chul Kim, Dug Keun Lee, Alan T. Remaley, Fredrick S. Leach, Ronald A. Morton, Seong‐Jin Kim	59
8	INDICATIONS FOR PELVIC LYMPHADENECTOMY IN PROSTATE CANCER 2001 ·Urologic Clinics of North America ·(unknown), Ronald A. Morton	45
9	Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues. 2000 ·PubMed ·Isaac Yi Kim, Dong Hyeon Lee, Han Jong Ahn, Hideo Tokunaga, Weitao Song, (unknown), Donald Jin, T. Kuber Sampath, Ronald A. Morton	83
10	Race is not an independent predictor of positive surgical margins after radical prostatectomy 1999 ·Urology ·(unknown), Michael W. Kattan, Justin M. Albani, David S. Sharp, James A. Eastham, Ronald A. Morton	16
11	Molecular Biology of Prostate Cancer 1998 ·PubMed ·William B. Isaacs, G. Steven Bova, Ronald A. Morton, Marion J.G. Bussemakers, James D. Brooks, Charles M. Ewing	56
12	Hypermethylation of Chromosome 17P Locust D17S5 in Human Prostate Tissue 1996 ·The Journal of Urology ·Ronald A. Morton, John J. Watkins, G. Steven Bova, (unknown), Stephen B. Baylin, William B. Isaacs	32
13	The E-cadherin cell-cell adhesion pathway in urologic malignancies 1995 ·World Journal of Urology ·Ronald A. Morton, Charles M. Ewing, John J. Watkins, William B. Isaacs	15
14	Molecular biology of prostate cancer progression. 1995 ·PubMed ·William B. Isaacs, G. Steven Bova, Ronald A. Morton, Marion J.G. Bussemakers, James D. Brooks, Charles M. Ewing	42
15	Racial differences in adenocarcinoma of the prostate in North American men 1994 ·Urology ·Ronald A. Morton	115
16	Genetic Alterations in Prostate Cancer 1994 ·Cold Spring Harbor Symposia on Quantitative Biology ·William B. Isaacs, G. Steven Bova, Ronald A. Morton, Marion J.G. Bussemakers, James D. Brooks, Charles M. Ewing	44
17	Assignment of the Human α-Catenin Gene (CTNNA1) to Chromosome 5q21-q22 1994 ·Genomics ·John D. McPherson, Ronald A. Morton, Charles M. Ewing, John J. Wasmuth, Joan Overhauser, Akira Nagafuchi, Shöichiro Tsukita, William B. Isaacs	30
18	Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. 1993 ·PubMed ·Ronald A. Morton, Charles M. Ewing, Akira Nagafuchi, Sachiko Tsukita, William B. Isaacs	250
19	MRI of the Renal Veins 1992 ·Journal of Computer Assisted Tomography ·Clare M. Tempany, Ronald A. Morton, Fray F. Marshall	13
20	Differential effects of growth factor antagonists on neoplastic and normal prostatic cells 1990 ·The Prostate ·Ronald A. Morton, John T. Isaacs, William B. Isaacs	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact